|
1
|
Linke WA and Bücker S: King of hearts: a
splicing factor rules cardiac proteins. Nat Med. 18:6602012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyer L, Stubbs B, Fahrenbruch C, et al:
Incidence, causes and survival trends from cardiovascular-related
sudden cardiac arrest in children and young adults 0 to 35 years of
age a 30-year review. Circulation. 126:1363–1372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tachibana M, Sugimoto K, Fukushima T and
Shinkai Y: Set domain-containing protein, G9a, is a novel
lysine-preferring mammalian histone methyltransferase with
hyperactivity and specific selectivity to lysines 9 and 27 of
histone H3. J Biol Chem. 276:25309–25317. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Albert M and Peters AH: Genetic and
epigenetic control of early mouse development. Curr Opin Genet Dev.
19:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feldman N, Gerson A, Fang J, et al:
G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during
early embryogenesis. Nat Cell Biol. 8:188–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen MW, Hua KT, Kao HJ, et al: H3K9
histone methyltransferase G9a promotes lung cancer invasion and
metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer
Res. 70:7830–7840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devaux B, Scholz D, Hirche A, Klövekorn WP
and Schaper J: Upregulation of cell adhesion molecules and the
presence of low grade inflammation in human chronic heart failure.
Eur Heart J. 18:470–479. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blankenberg S, Rupprecht HJ, Bickel C, et
al: Circulating cell adhesion molecules and death in patients with
coronary artery disease. Circulation. 104:1336–1342. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin WH, Chen JW, Jen HL, et al: The
prognostic value of circulating soluble cell adhesion molecules in
patients with chronic congestive heart failure. Eur J Heart Fail.
5:507–516. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noutsias M, Seeberg B, Schultheiss H-P and
Kühl U: Expression of cell adhesion molecules in dilated
cardiomyopathy evidence for endothelial activation in inflammatory
cardiomyopathy. Circulation. 99:2124–2131. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watanabe K, Ohta Y, Nakazawa M, et al: Low
dose carvedilol inhibits progression of heart failure in rats with
dilated cardiomyopathy. Br J Pharmacol. 130:1489–1495. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chadfield MS and Hinton MH: In vitro
activity of nitrofuran derivatives on growth and morphology of
Salmonella enterica serotype enteritidis. J Appl Microbiol.
96:1002–1012. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jankus E, Noren G and Staley N:
Furazolidone-induced cardiac dilatation in turkeys. Avian Dis.
16:958–961. 1972. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao R, Nascimben L, Friedrich J, Gwathmey
JK and Ingwall JS: Decreased energy reserve in an animal model of
dilated cardiomyopathy relationship to contractile performance.
Circ Res. 78:893–902. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Czarnecki CM: Animal models of
drug-induced cardiomyopathy. Comp Biochem Physiol Part C. 79:9–14.
1984. View Article : Google Scholar
|
|
16
|
Huang RJ, Liu TW, Wu WF and Pang YS:
Furazolidone induces dilated cardiomyopathy in rats [J]. Chinese J
Pathophysiol. 11:2005.
|
|
17
|
Kubota T, McTiernan CF, Frye CS, et al:
Dilated cardiomyopathy in transgenic mice with cardiac-specific
overexpression of tumor necrosis factor-α. Circ Res. 81:627–635.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stein AB, Tiwari S, Thomas P, et al:
Effects of anesthesia on echocardiographic assessment of left
ventricular structure and function in rats. Basic Res Cardiol.
102:28–41. 2007. View Article : Google Scholar
|
|
19
|
Delles M, Rengier F, Jeong YJ, et al:
Estimation of aortic pressure waveforms from 4D phase-contrast MRI.
Conf Proc IEEE Eng Med Biol Soc. 2013:731–734. 2013.PubMed/NCBI
|
|
20
|
Patel AR, Alsheikh-Ali AA, Mukherjee J, et
al: 3D echocardiography to evaluate right atrial pressure in
acutely decompensated heart failure correlation with invasive
hemodynamics. JACC Cardiovasc Imaging. 4:938–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldberg MR, Tanaka W, Barchowsky A, et
al: Effects of losartan on blood pressure, plasma renin activity
and angiotensin II in volunteers. Hypertension. 21:704–713. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kodish ME and Katz FH: Plasma renin
concentration: comparison of angiotensinase inhibitors and
correlation with plasma renin activity and aldosterone. J Lab Clin
Med. 83:705–715. 1974.PubMed/NCBI
|
|
23
|
Takano S, Yoshitomi H, Togawa A, et al:
Apolipoprotein C-1 maintains cell survival by preventing from
apoptosis in pancreatic cancer cells. Oncogene. 27:2810–2822. 2008.
View Article : Google Scholar
|
|
24
|
Guo Z, Wang S, Jiao Q, Xu M and Gao F:
RNAi targeting ryanodine receptor 2 protects rat cardiomyocytes
from injury caused by simulated ischemia-reperfusion. Biomed
Pharmacother. 64:184–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carleton KL: Quantification of transcript
levels with quantitative RT-PCR. Methods Mol Biol. 772:279–295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Purcell NH, Tang G, Yu C, Mercurio F,
DiDonato JA and Lin A: Activation of NF-kappa B is required for
hypertrophic growth of primary rat neonatal ventricular
cardiomyocytes. Proc Nat Acad Sci USA. 98:6668–6673. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moon C, Krawczyk M, Ahn D, et al:
Erythropoietin reduces myocardial infarction and left ventricular
functional decline after coronary artery ligation in rats. Proc Nat
Acad Sci. 100:11612–11617. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paulus WJ, Tschöpe C, Sanderson JE, et al:
How to diagnose diastolic heart failure: a consensus statement on
the diagnosis of heart failure with normal left ventricular
ejection fraction by the heart failure and echocardiography
associations of the european society of cardiology. Eur Heart J.
28:2539–2550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Avolio A: Central aortic blood pressure
and cardiovascular risk a paradigm shift? Hypertension.
51:1470–1471. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bombardini T, Cini D, Arpesella G and
Picano E: WEB downloadable software for training in cardiovascular
hemodynamics in the (3-D) stress echo lab. Cardiovasc Ultrasound.
8:482010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vander AJ: Control of renin release.
Physiol Rev. 47:359–382. 1967.PubMed/NCBI
|
|
32
|
Gigante B, Rubattu S, Russo R, et al:
Opposite feedback control of renin and aldosterone biosynthesis in
the adrenal cortex by angiotensin II AT1-subtype receptors.
Hypertension. 30(3 Pt 2): 563–568. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sarafidis PA and Ruilope LM: Aggressive
blood pressure reduction and renin-angiotensin system blockade in
chronic kidney disease: time for re-evaluation? Kidney Int.
85:536–546. 2014. View Article : Google Scholar
|
|
34
|
Podwysocki B, Simon K and Gladysz A:
Activity of angiotensin converting enzyme I and levels of acid
alpha glycoprotein in selected liver and biliary tract diseases.
Pol Tyg Lek. 48:268–270. 1993.(In Polish). PubMed/NCBI
|
|
35
|
Aoyagi T, Izumi Y, Hiroyama M, et al:
Vasopressin regulates the renin-angiotensin-aldosterone system via
V1a receptors in macula densa cells. Am J Physiol Renal Physiol.
295:F100–F107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Erdös EG and Skidgel RA: Renal metabolism
of angiotensin I and II. Kidney Int Suppl. 30:S24–S27.
1990.PubMed/NCBI
|
|
37
|
Johnston CI: Renin-angiotensin system: a
dual tissue and hormonal system for cardiovascular control. J
Hypertens. 10:S271992. View Article : Google Scholar
|
|
38
|
Ohtani K, Yutani C, Nagata S, Koretsune Y,
Hori M and Kamada T: High prevalence of atrial fibrosis in patients
with dilated cardiomyopathy. J Am Coll Cardiol. 25:1162–1169. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang M, Shan H, Zhu Y-h, Lin L and Wei J:
Attenuating effect of estrogen on furazolidone induced
cardiomyocyte apoptosis is dependent on p66shc adapter protein.
cardiology karger allschwilerstrasse 10, ch-4009 Basel,
Switzerland: pp. 34. 2013
|
|
40
|
Genao A, Seth K, Schmidt U, Carles M and
Gwathmey JK: Dilated cardiomyopathy in turkeys: an animal model for
the study of human heart failure. Lab Anim Sci. 46:399–404.
1996.PubMed/NCBI
|
|
41
|
Tachibana M, Sugimoto K, Nozaki M, et al:
G9a histone methyltransferase plays a dominant role in euchromatic
histone H3 lysine 9 methylation and is essential for early
embryogenesis. Genes Dev. 16:1779–1791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Roopra A, Qazi R, Schoenike B, Daley TJ
and Morrison JF: Localized domains of G9a-mediated histone
methylation are required for silencing of neuronal genes. Mol Cell.
14:727–738. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hohl M, Wagner M, Reil JC, et al: HDAC4
controls histone methylation in response to elevated cardiac load.
J Clin Invest. 123:1359–1370. 2013. View
Article : Google Scholar : PubMed/NCBI
|
